ツムラの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/07/16 | 3,475 | 3,485 | 3,445 | 3,445 | -30 | -0.9% | 79,000 |
2021/07/15 | 3,530 | 3,535 | 3,475 | 3,475 | -95 | -2.7% | 109,700 |
2021/07/14 | 3,465 | 3,580 | 3,460 | 3,570 | +80 | +2.3% | 108,900 |
2021/07/13 | 3,515 | 3,525 | 3,490 | 3,490 | +20 | +0.6% | 93,200 |
2021/07/12 | 3,430 | 3,495 | 3,415 | 3,470 | +110 | +3.3% | 132,100 |
2021/07/09 | 3,315 | 3,370 | 3,285 | 3,360 | -25 | -0.7% | 194,400 |
2021/07/08 | 3,370 | 3,415 | 3,370 | 3,385 | -10 | -0.3% | 168,000 |
2021/07/07 | 3,380 | 3,415 | 3,360 | 3,395 | -50 | -1.5% | 105,500 |
2021/07/06 | 3,475 | 3,475 | 3,440 | 3,445 | ±0 | ±0% | 67,000 |
2021/07/05 | 3,465 | 3,495 | 3,440 | 3,445 | -55 | -1.6% | 79,700 |
2021/07/02 | 3,530 | 3,545 | 3,495 | 3,500 | ±0 | ±0% | 120,200 |
2021/07/01 | 3,495 | 3,515 | 3,475 | 3,500 | +5 | +0.1% | 82,400 |
2021/06/30 | 3,560 | 3,580 | 3,490 | 3,495 | -5 | -0.1% | 171,900 |
2021/06/29 | 3,515 | 3,530 | 3,490 | 3,500 | -80 | -2.2% | 151,200 |
2021/06/28 | 3,580 | 3,590 | 3,555 | 3,580 | +15 | +0.4% | 98,300 |
2021/06/25 | 3,580 | 3,590 | 3,555 | 3,565 | ±0 | ±0% | 89,900 |
2021/06/24 | 3,490 | 3,575 | 3,485 | 3,565 | +5 | +0.1% | 146,700 |
2021/06/23 | 3,530 | 3,590 | 3,525 | 3,560 | +5 | +0.1% | 87,900 |
2021/06/22 | 3,475 | 3,560 | 3,455 | 3,555 | +85 | +2.4% | 172,200 |
2021/06/21 | 3,470 | 3,490 | 3,400 | 3,470 | -65 | -1.8% | 237,300 |
2021/06/18 | 3,640 | 3,640 | 3,510 | 3,535 | -80 | -2.2% | 372,700 |
2021/06/17 | 3,605 | 3,625 | 3,585 | 3,615 | -25 | -0.7% | 123,400 |
2021/06/16 | 3,595 | 3,645 | 3,585 | 3,640 | +45 | +1.3% | 136,400 |
2021/06/15 | 3,685 | 3,685 | 3,565 | 3,595 | -110 | -3% | 179,700 |
2021/06/14 | 3,800 | 3,800 | 3,700 | 3,705 | -60 | -1.6% | 125,200 |
2021/06/11 | 3,770 | 3,770 | 3,705 | 3,765 | +65 | +1.8% | 188,300 |
2021/06/10 | 3,650 | 3,725 | 3,650 | 3,700 | +60 | +1.6% | 154,600 |
2021/06/09 | 3,630 | 3,675 | 3,630 | 3,640 | -5 | -0.1% | 97,000 |
2021/06/08 | 3,625 | 3,685 | 3,600 | 3,645 | +90 | +2.5% | 168,800 |
2021/06/07 | 3,600 | 3,600 | 3,515 | 3,555 | +20 | +0.6% | 136,300 |
2021/06/04 | 3,550 | 3,550 | 3,500 | 3,535 | +55 | +1.6% | 171,500 |
2021/06/03 | 3,485 | 3,525 | 3,470 | 3,480 | +35 | +1% | 137,100 |
2021/06/02 | 3,425 | 3,475 | 3,410 | 3,445 | -10 | -0.3% | 165,700 |
2021/06/01 | 3,520 | 3,520 | 3,430 | 3,455 | +5 | +0.1% | 142,400 |
2021/05/31 | 3,540 | 3,555 | 3,435 | 3,450 | -115 | -3.2% | 132,600 |
2021/05/28 | 3,560 | 3,585 | 3,530 | 3,565 | +50 | +1.4% | 171,800 |
2021/05/27 | 3,500 | 3,535 | 3,495 | 3,515 | -20 | -0.6% | 178,200 |
2021/05/26 | 3,555 | 3,560 | 3,525 | 3,535 | -35 | -1% | 178,100 |
2021/05/25 | 3,550 | 3,570 | 3,535 | 3,570 | +20 | +0.6% | 135,200 |
2021/05/24 | 3,505 | 3,580 | 3,505 | 3,550 | +40 | +1.1% | 115,100 |
2021/05/21 | 3,510 | 3,540 | 3,475 | 3,510 | +10 | +0.3% | 124,500 |
2021/05/20 | 3,470 | 3,520 | 3,465 | 3,500 | +25 | +0.7% | 107,900 |
2021/05/19 | 3,535 | 3,550 | 3,455 | 3,475 | +5 | +0.1% | 159,000 |
2021/05/18 | 3,405 | 3,475 | 3,395 | 3,470 | +40 | +1.2% | 93,400 |
2021/05/17 | 3,505 | 3,515 | 3,415 | 3,430 | -65 | -1.9% | 103,800 |
2021/05/14 | 3,495 | 3,535 | 3,465 | 3,495 | -10 | -0.3% | 114,300 |
2021/05/13 | 3,385 | 3,560 | 3,385 | 3,505 | +110 | +3.2% | 280,500 |
2021/05/12 | 3,610 | 3,620 | 3,375 | 3,395 | -285 | -7.7% | 322,800 |
2021/05/11 | 3,720 | 3,735 | 3,670 | 3,680 | -50 | -1.3% | 287,000 |
2021/05/10 | 3,710 | 3,745 | 3,675 | 3,730 | +40 | +1.1% | 119,500 |
951~
1000
件表示中 / 3715件
類似銘柄と比較する
現在ご覧いただいている「ツムラ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ツムラ | 333,200円 | +3.8% | -19.9% | 4.08% | 10.90倍 | 0.83倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
久光薬 | 407,800円 | +5.8% | +1.2% | 2.94% | 13.52倍 | 1.08倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
住友ファーマ | 80,400円 | -11.0% | +206.6% | 0.00% | 7.99倍 | 1.88倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
日本新薬 | 353,400円 | +8.0% | -15.3% | 3.51% | 9.92倍 | 0.96倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
サンバイオ | 338,000円 | - | - | 0.00% | - | 156.55倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム